LifeMD Reports Fourth Quarter and Full Year 2025 Results
LifeMD, Inc. (LFMD)
Company Research
Source: GlobeNewswire
Full year 2025 revenue grew 25% to $194.1 million; adjusted EBITDA rose 309% to $15.3 million.Fourth quarter revenue increased 4% to $46.9 million; adjusted EBITDA rose 348% to $4.8 million.Successfully launched oral Wegovy subsequent to year end, with over 80% of new weight management patients initiating branded therapy and Q1 sign-ups at record levels.Exited 2025 with $36.8 million of cash and no debt, positioning LifeMD for accelerated investments in growth.Benefits infrastructure on track to cover approximately 220 million Americans in second quarter; women’s health offering seeing strong early patient growth. Conference call begins at 4:30 p.m. Eastern time today NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today reported financial results for the fourth quarter and year ended December 31, 2025. Management Commentary “LifeMD delivered strong fourth quarter results across all business lines and
Show less
Read more
Impact Snapshot
Event Time:
LFMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LFMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LFMD alerts
High impacting LifeMD, Inc. news events
Weekly update
A roundup of the hottest topics
LFMD
News
- LifeMD appoints Atul Kavthekar as CFO [Seeking Alpha]Seeking Alpha
- LifeMD (LFMD) was upgraded by Mizuho from "neutral" to "outperform". They now have a $8.00 price target on the stock, up from $6.00.MarketBeat
- LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership TeamGlobeNewswire
- LifeMD (LFMD) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=LFMD&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "sell" to "hold".MarketBeat
- LifeMD (LFMD) was given a new $10.00 price target by Loop Capital.MarketBeat
LFMD
Earnings
- 3/9/26 - Beat
LFMD
Sec Filings
- 3/18/26 - Form 8-K
- 3/10/26 - Form 10-K
- 3/9/26 - Form 8-K
- LFMD's page on the SEC website